Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.
Hesdorffer C, Ayello J, Ward M, Kaubisch A, Vahdat L, Balmaceda C, Garrett T, Fetell M, Reiss R, Bank A, Antman K. Hesdorffer C, et al. Among authors: fetell m. J Clin Oncol. 1998 Jan;16(1):165-72. doi: 10.1200/JCO.1998.16.1.165. J Clin Oncol. 1998. PMID: 9440739 Clinical Trial.
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
Papadopoulos KP, Garvin JH, Fetell M, Vahdat LT, Garrett TJ, Savage DG, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: fetell m. Bone Marrow Transplant. 1998 Oct;22(7):661-7. doi: 10.1038/sj.bmt.1701408. Bone Marrow Transplant. 1998. PMID: 9818693
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Antman KH, Hesdorffer CS. Papadopoulos KP, et al. Among authors: fetell m. J Neurooncol. 1999 Sep;44(2):155-62. doi: 10.1023/a:1006391619009. J Neurooncol. 1999. PMID: 10619499 Clinical Trial.
Human MDR gene transfer in patients with advanced cancer.
Hesdorffer C, Antman K, Bank A, Fetell M, Mears G, Begg M. Hesdorffer C, et al. Among authors: fetell m. Hum Gene Ther. 1994 Sep;5(9):1151-60. doi: 10.1089/hum.1994.5.9-1151. Hum Gene Ther. 1994. PMID: 7833373 Clinical Trial. No abstract available.
Nevus of Ota and leptomeningeal melanocytic lesions.
Balmaceda CM, Fetell MR, O'Brien JL, Housepian EH. Balmaceda CM, et al. Among authors: fetell mr. Neurology. 1993 Feb;43(2):381-6. doi: 10.1212/wnl.43.2.381. Neurology. 1993. PMID: 8437707 Review.
Supratentorial ependymomas in adult patients.
Schwartz TH, Kim S, Glick RS, Bagiella E, Balmaceda C, Fetell MR, Stein BM, Sisti MB, Bruce JN. Schwartz TH, et al. Among authors: fetell mr. Neurosurgery. 1999 Apr;44(4):721-31. doi: 10.1097/00006123-199904000-00018. Neurosurgery. 1999. PMID: 10201296
43 results